Continuous polyhydroxyalkanoate production by perchlorate respiring microorganisms

WO2024197106A3PCT designated stage expired Publication Date: 2024-11-28RGT UNIV OF CALIFORNIA
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/020829
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-21
Filing Date
2024-03-21
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Current PHA production is limited by the physiology of microorganisms, which restricts industrial production to inefficient batch fermentation processes, as they can either maximize cell density or PHA yield, but not both, especially under limited carbon resources.

Method used

Utilizing perchlorate-respiring microorganisms that produce PHA throughout their growth cycle by growing on perchlorate as an electron acceptor, enabling continuous polyhydroxyalkanoate production from organic acids in a bioreactor.

Benefits of technology

This approach allows for continuous PHA production with yields comparable to commercial processes, achieving up to 0.18g/L/OD600 and 0.12kg/kg acetate, significantly increasing productivity and efficiency, making it suitable for industrial-scale continuous bioprocessing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 000001
    Figure 000001
  • Figure 000002
    Figure 000002
  • Figure 000003
    Figure 000003
Patent Text Reader

Abstract

Continuous polyhydroxyalkanoate production by perchlorate respiring microorganisms utilizes the unique ability of microorganisms growing on perchlorate to produce PHA throughout their growth cycle.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Continuous Polyhydroxyalkanoate Production by Perchlorate Respiring Microorganisms

[0002]

[0001] Cross-references to related applications

[0003]

[0002] This application claims priority to U.S. Provisional Application No. 63 / 453,736; filed: Mar 21, 2023, the disclosure of which are hereby incorporated by reference in its entirety for all purposes.

[0004]

[0003] Introduction

[0005]

[0004] Annually plastic production exceeds 300 gigatonnes of which less than 10% are recycled. The remainder end up in landfills or contaminate our environment. Natural biogenic plastics offer an attractive alternative that can be produced sustainably and are readily biodegradable. Of the plethora of bioplastics produced by microorganisms polyhydroxyalkanoates (PHA) offer great potential because of the huge diversity of chemical structures and simple biodegradation through composting in both marine and freshwater environments. The global demand for bioplastics is increasing and the 2019 market value of $8.3B is expected to reach a compound annual growth rate (CAGR) of 16.1% from 2020-2027 (https: / / www.grandviewresearch.com / industry-analysis / bioplastics-industry). However, efficient PHA production is constrained by the underlying physiology of the microorganisms which produce them.

[0006]

[0005] Microorganisms use PHA as a carbon storage mechanism when incubated under a limiting nutrient condition (e.g. nitrogen, phosphorous, or sulfur). The synthesized PHA are subsequently reutilized when the depleted nutrient is replenished. As such, when the organism is unable to reproduce, it alters its metabolism to synthesize PHA bioplastics instead. Thus, to maximize cell density in order to maximize PHA yield provides a dilemma: in an environment of limited carbon resources, it is either one or the other, but not both. For this reason, industrial PHA production is restricted to highly inefficient and costly batch fermentation processes and do not take advantage of the advances that are being made in precision continuous fermentation technologies.

[0007]

[0006] Summary of the Invention

[0008]

[0007] The invention provides continuous polyhydroxyalkanoate production by perchlorate respiring microorganisms utilizing the unique ability of microorganisms growing on perchlorate to produce PHA throughout their growth cycle.

[0009]

[0008] In aspects the invention provides method, composition, system or device configured for the methods herein, such as a bioreactor.

[0009] In an aspect the invention provides a method of continuous polyhydroxyalkanoate production by perchlorate respiring microbes comprising growing the microbes on perchlorate as an electron acceptor to produce PHA from an organic acid, throughout their growth cycle.

[0010] In an aspect the invention provides a continuous fermentation bioreactor configured for continuous polyhydroxyalkanoate production by perchlorate respiring microbes comprising growing the microbes on perchlorate as an electron acceptor to produce PHA from a waste organic acid, throughout their growth cycle.

[0010] [Oil] In embodiments:

[0011]

[0012] wherein the organic acid is selected from acetate, propionate, butyrate, isobutyrate, valerate and isovalerate;

[0012]

[0013] the PHA is selected from polyhydroxybutyrate (PHB), polyhydroxy valerate (PHV), polyhydroxyhexanoate (PHHX) and polyhydroxyoctanoate (PHO);

[0013]

[0014] the PHA is a homopolymer, a random copolymer, a block polymer, or mixed homo- and block- polymer;

[0014]

[0015] the microbes comprise and express genes encoding a PHA synthesis pathway sufficient for PHA synthesis, including genes encoding: b-ketothiolase, acetoacetyl-CoA reductase, and PHA synthase;

[0015]

[0016] the microbes naturally express the genes encoding the PHA synthesis pathways;

[0016]

[0017] the microbes are engineered to express the genes encoding the PHA synthesis pathways;

[0018] the microbes are engineered to comprise reduced PHA depolymerase gene expression;

[0017]

[0019] the microbes are engineered to comprise a PHA depolymerase gene knock out;

[0018]

[0020] the microbes are grown anaerobically;

[0019]

[0021] the microbes are Azospira or Dechloromonas;

[0020]

[0022] the microbes are Azospira suillum strain PS;

[0021]

[0023] the microbes are Azospira or Dechloromonas; and / or

[0022]

[0024] the microbes are Dechloromonas agitata strain CKB.

[0023]

[0025] The invention encompasses all combinations of the particular embodiments recited herein, as if each combination had been laboriously recited.

[0024]

[0026] Brief Description of the Drawings

[0025]

[0027] Fig. 1. Cell growth and PHA production by A. suillum when grown aerobically or anaerobically on perchlorate. Unusually, A. suillum produces PHA throughout the growth cycle with perchlorate. Growth is shown as cell density expressed in optical density units at 600nm. PHA production is expressed as PHA per optical density unit to allow comparison of yields across the two growth conditions.

[0028] Fig. 2. Growth and PHA production by A. suillum anaerobically on a range of different substrates with perchlorate as the electron acceptor. For comparison, A. suillum was grown aerobically with acetate.

[0026]

[0029] Fig. 3. PHA monomer production profile across a range of different carbon substrates.

[0030] Fig. 4. Polyhydroxyalkanoate production by the perchlorate reducer Azospira suillum strain PS when growing with perchlorate or oxygen as alternative electron acceptors. The data shows that in contrast to oxygen, the PHA is produced during growth on perchlorate and the PHA yield is significantly (4x) higher. Under aerobic conditions, the PHA is produced once growth is complete and are rapidly reconsumed during death phase.

[0027]

[0031] Fig. 5. Specific PHA yields under aerobic and perchlorate respiring conditions.

[0028]

[0032] Fig. 6. Continuous PHA fermentation schematic.

[0029]

[0033] Description of Particular Embodiments of the Invention

[0030]

[0034] Unless contraindicated or noted otherwise, in these descriptions and throughout this specification, the terms “a” and “an” mean one or more, the term “or” means and / or. ft is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and scope of the appended claims. All publications, patents, and patent applications cited herein, including citations therein, are hereby incorporated by reference in their entirety for all purposes.

[0035] The invention provides methods, systems and compositions utilizing perchlorate reducing bacteria growing on perchlorate as an electron acceptor to produce PHA from waste organic acids such as acetate throughout their growth cycle (Fig. 4); significantly, the reactor continuously produces PHA during growth (Fig. 4). Quantification demonstrates there was no significant difference between the amount of PHA produced per unit biomass under nitrogen limiting conditions relative to non-limiting conditions demonstrating that culture conditions can be readily optimized for PHA production without impairing final cell yields. Under these conditions, PHA productivity was equivalent to many of the known commercial processes already in existence with yields of up to 0.18g / L / OD600 PHA (Fig. 5). This equates to a PHA yield of 0.12kg / kg acetate. Even before optimization this compares favorably to organisms using glucose (0.44 kg / kg).

[0031]

[0036] Continuous cultures are on average ten times more productive than batch cultures. Our continuous culture experiments (Fig. 6) established the initial system calibration for the bioreactor, and demonstrate daily yield significantly greater than current commercial processes. In subsequent studies, we couple PHA production by A. suillum to biowaste conversion to directly valorize a waste stream into PHA.

[0032]

[0037] Examples

[0033]

[0038] A. suillum produces PHA throughout the growth cycle. Traditional PHA production is normally an inefficient batch two-phase process where cells are initially grown to maximize cell yield and then the grown cells are induced to produce PHA under non-growth conditions. Our studies with A. suillum grown under aerobic conditions with acetate revealed a similar PHA production profile to traditional PHA production processes. In this instance the organism only produced PHA at the end of its growth cycle as it moved into stationary phase (Fig. 1 ) due to nutrient depletion in the medium. In contrast, when grown anaerobically with perchlorate, A. suillum produced significant quantities of PHA throughout the growth cycle. Furthermore, A. suillum showed a four fold increase in PHA production under perchlorate reducing conditions compared to aerobic conditions (0.8g PHA / OD v’s 0.2g PHA / OD). These findings demonstrate capacity for industrial production as it means that PHA bioprocessing can be performed in continuous process instead of in a batch process as is the basis for current PHA manufacture. In general, continuous bioprocesses are approximately 6-10 times more efficient because of losses in downtime of traditional batch systems.

[0034]

[0039] PHA yields by A. suillum were substrate specific and the highest yields were observed with fumarate as sole substrate, followed by butyrate and lactate (Fig. 2). While PHA yields on fumarate were nearly 1.5 times that observed on butyrate, maximum PHA production was only observed after 50 hours incubation. By contrast, maximum PHA production with butyrate as the sole substrate occurred within the first 20 hours of growth. Furthermore, cell yields of A. suillum were twofold higher with butyrate as the substrate (Fig. 2). Butyrate is an organic acid commonly found in waste streams whereas, fumarate is a highly valued organic with application across the chemical and food industry. For example, butyrate is a major component of swine waste where it is often measured at concentrations of ~40mM (3484ppm).

[0035]

[0040] PH As represent polymers of a diverse range of fatty acid monomers. As such, they all share a common repeating polyester structure but differ in the length of the alkane functional group. Examples include polyhydroxybutyrate (PHV), polyhydroxyvalerate (PHV), polyhydroxyhexanoate (PHHX), and polyhydroxyoctanoate (PHO), marking the onset of medium-chain PHAs. PHA compositions vary, ranging from pure homopolymers to mixed homo- and block-polymers, offering versatile material properties. Mixed PHAs exhibit superior thermal plasticity compared to PHA homopolymers, making them promising candidates for replacing current petrochemical plastics. We established an efficient chemical extraction and analysis procedures based on gas chromatography mass spectrometry to identify the monomeric components of the PHA molecules being synthesized by A. suillum. Our results revealed that A. suillum produces three different PHA monomers (hydroxybutyrate [HB], hydroxy valerate [HV], and hydroxoxtanoate [HO]). Investigation into HB to HV ratios in the PHA produced by PS with a range of different carbon substrates (acetate, lactate, propionate, butyrate, fumarate, and succinate) with perchlorate as the sole electron acceptor revealed that the ratio of the individual monomers produced in the PHA is carbon substrate specific (Fig. 3). Propionate yields the most evenly mixed polymer with a ration of HB-HV of ~50%:50%. This is an useful feature as a copolymer of PHB / PHV is generally considered to demonstrate superior material properties compared to pure PHB or PHV.

[0036]

[0041] The A. suillum PHA biochemical pathway comprises four genes encoding the b- ketothiolase, acetoacetyl-CoA reductase, PHA synthase, and the PHA depolymerase respectively. The PHA depolymerase is used by the organism when it comes into an environment replete with the missing nutrient that was limiting its growth (e.g. phosphorous). Under these conditions, the organism depolymerizes its PHA resources inside the cell and catabolizes these to make more cells. In our growth curves this can be seen as the loss of PHA after the maximum yield has been obtained. To prevent this reaction, we can genetically modify A. suillum to knock out the phaZ gene which encodes for the PHA depolymerase. In the absence of this gene, the organism is still able to make PHA but is unable to consume the synthesized bioplastic, thus maximizing PHA yields. In short, we identified the specific gene targets associated with both PHA production and depolymerization in A. suillum. These targets were validated using TIGRFAMs, confirming the presence of conserved sequences as markers for gene function. Following gene function determination, suicide plasmids were designed to create genetic knockouts that were incapable of PHA consumption.

Claims

CLAIMS1 . A method of continuous polyhydroxyalkanoate production by a perchlorate respiring microbes comprising growing the microbes on perchlorate as an electron acceptor to produce a polyhydroxyalkanoate (PHA) from an organic acid throughout their growth cycle.

2. The method of claim 1, wherein the organic acid is selected from acetate, propionate, butyrate, isobutyrate, valerate and isovalerate.

3. The method of claim 1, wherein the PHA is selected from polyhydroxybutyrate (PHB), polyhydroxyvalerate (PHV), polyhydroxyhexanoate (PHHX) and polyhydroxyoctanoate (PHO).

4. The method of claim 1, wherein the PHA is a homopolymer, a random copolymer, a block polymer, or mixed homo- and block- polymer.

5. The method of claim 1 , wherein microbes comprise and express genes encoding a PHA synthesis pathway sufficient for PHA synthesis, including genes encoding: b-ketothiolase, acetoacetyl-CoA reductase, and PHA synthase.

6. The method of claim 5, wherein the microbes naturally express the genes encoding the PHA synthesis pathways.

7. The method of claim 5, wherein the microbes are engineered to express the genes encoding the PHA synthesis pathways.

8. The method of claim 1, wherein the microbes are engineered to comprise reduced PHA depolymerase gene expression.

9. The method of claim 1, wherein the microbes are engineered to comprise a PHA depolymerase gene knock out.

10. The method of claim 1 wherein the microbes are grown anaerobically.1 1. The method of any of claims 1-10, wherein the microbes are Azospira or Dechloromonas.

12. The method of any of claims 1-10, wherein the microbes are Azospira suillum strain PS.

13. The method of any of claims 1-10, wherein the microbes are Azospira or Dechloromonas.

14. The method of any of claims 1-10, wherein the microbes are Dechloromonas agitata strain CKB.

15. A continuous fermentation bioreactor configured for continuous polyhydroxyalkanoate production by perchlorate respiring microbes comprising growing the microbes on perchlorate as an electron acceptor to produce PHA according to a method of any of claims 1-10.

Citation Information

Patent Citations

  • PHA-producing genetically engineered microorganisms

    US20150203878A1

  • Method for producing polyhydroxyalkanoate using 2-hydroxyisocaproate-coa transferase

    US20190352622A1

  • A bacterial consortium for reducing perchlorate and / or nitrate and the process thereof

    US20210147269A1

  • Microbial respiration of chloroxyanions as a source of oxygen for bioprocessing

    WO2022150258A1